Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
POU2AF1
REST API REST API
Homo sapiens
POU2AF1 is differentially expressed in 223 experiments: 111 organism parts: lymph node, tonsil, ... (109 more);, 195 disease states: normal, Burkitt's lymphoma, ... (193 more);, 100 cell types 384 cell lines 19 compound treatments and 62 other conditions.
Synonyms OBF1
Orthologs OBF1_BOVIN (Bos taurus)   Pou2af1 (Mus musculus)   Pou2af1 (Rattus norvegicus)   pou2af1 (Xenopus laevis)   POU2AF1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term humoral immune response, DNA binding, protein binding, regulation of transcription, DNA-dependent, transcription from RNA polymerase II promoter, transcription coactivator activity, transcription cofactor activity, nucleus
InterPro Term PD-C2-AF1
UniProt Accession Q16633, E9PKH4
Search EB-eye ENSG00000110777
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-17189, E-GEOD-22541, E-GEOD-1577, E-GEOD-3526, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-19639, E-GEOD-4342, E-MTAB-62, E-GEOD-19466, E-GEOD-21750, ... (26 experiments)

Factor Value U/D Experiments
MOLT4
2
E-MTAB-62, E-MTAB-37
Raji
2
E-MTAB-37, E-GEOD-96
SW480
2
E-MEXP-1014, E-MTAB-37
HL-60
1
2
E-GEOD-24147, E-GEOD-96, E-MTAB-37
NCIH322
1
E-MTAB-37
NCIH650
1
E-MTAB-37
378 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-120, E-MEXP-750, E-GEOD-4219, ... (41 experiments)

Factor Value U/D Experiments
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
CD14+ monocyte
2
E-AFMX-5, E-MEXP-1600
CD19+ B cells (neg. sel.)
2
E-AFMX-5, E-TABM-145
CD8+ T cell
2
E-AFMX-5, E-GEOD-6740
centroblast
2
E-TABM-702, E-GEOD-15271
endothelial cell
2
E-GEOD-19240, E-GEOD-3920
94 more value(s).


Disease state

studied in E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-MEXP-1121, E-TABM-15, ... (53 experiments)

Factor Value U/D Experiments
colon carcinoma
3
E-MTAB-37, E-MTAB-62, E-MTAB-57
control
3
E-GEOD-21912, E-GEOD-20295, E-GEOD-8121
septic shock
2
E-GEOD-8121, E-GEOD-9692
rheumatoid arthritis
2
E-GEOD-7307, E-GEOD-1919
acute promyelocytic leukemia
2
E-GEOD-96, E-MTAB-62
chronic lymphocytic leukemia
2
E-MTAB-37, E-GEOD-2466
189 more value(s).


Compound treatment

studied in E-MEXP-1601, E-MEXP-1269, E-GEOD-7400, E-GEOD-5258, E-GEOD-3284, ... (12 experiments)

Factor Value U/D Experiments
none
1
4
E-MEXP-1269, E-GEOD-5824, E-GEOD-1919, E-GEOD-7400, E-GEOD-412 ... (5 experiments)
5-aza-2'-deoxycytidine
2
2
E-MEXP-1269, E-GEOD-5230
bacterial endotoxin
1
E-GEOD-3284
control
1
E-GEOD-3284
HMB-PP (phosphoantigen)
1
1
E-MEXP-1601
phenol
1
E-GEOD-6907
13 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
63
2
1
E-GEOD-21653


Age at onset
studied in E-GEOD-21521

Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-2191, E-GEOD-21374, ... (12 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-3891, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-MTAB-69, E-GEOD-19665

Environmental stress
studied in E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MTAB-108

Genotype
studied in E-TABM-1029, E-GEOD-22056, E-MEXP-149, E-GEOD-2466, E-MEXP-421, ... (9 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-20540, E-GEOD-22278, E-GEOD-9764, E-MEXP-1273, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-GEOD-974, E-GEOD-2466, ... (39 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-9723, E-MEXP-561

Injury
studied in E-GEOD-19743

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-22229, E-GEOD-19703, E-GEOD-21750, E-MEXP-1403

Population
studied in E-MTAB-197

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19246

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

RNAi
studied in E-MEXP-101, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11428

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-19246, E-GEOD-19815, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Processing time: 0.581 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM